Stocks and Investing Stocks and Investing
Mon, May 15, 2023
Fri, May 12, 2023

David Nierengarten Reiterated (VOR) at Buy and Held Target at $18 on, May 12th, 2023


Published on 2024-10-28 03:45:00 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Reiterated "Vor Biopharma Inc." (VOR) at Buy and Held Target at $18 on, May 12th, 2023.

David has made no other calls on VOR in the last 4 months.



There are 5 other peers that have a rating on VOR. Out of the 5 peers that are also analyzing VOR, 0 agree with David's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with David


  • Jack Allen of "Baird" Maintained at Buy with Decreased Target to $22 on, Friday, March 24th, 2023
  • Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $18 on, Friday, March 24th, 2023
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $12 on, Friday, March 24th, 2023
  • Stephen Willey of "Truist Securities" Maintained at Strong Buy with Decreased Target to $16 on, Friday, March 24th, 2023
  • Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $18 on, Friday, March 24th, 2023